A unique complex of "BIOS" creams against psoriasis, atopic dermatitis and neurodermatitis

Skin regeneration system based on bioactive retinoids

Biomolecular cosmetics

Designed to combat diseases such as psoriasis, atopic dermatitis and neurodermatitis

For children of 1 year
old and above

For adults

Pace of life and stress are the main factors of the appearance of neurodermatitis and psoriasis in middle-aged people. Hormonal agents do not solve the problem; they cause dependence and the affected area on the skin increases.

For the elderly

With aging, the barrier functions of the skin decrease, which multiplies the risk of skin diseases.

New food, ecology, care products, blooms and other factors can cause undesirable skin manifestations.

Learn more about the unique BIOS skin regeneration system
The system returns your skin to its natural state, and,at the same time, the skin becomes smooth, soft and pleasantly elastic. Wrinkles are smoothed out, and the skin colour gets a fresh, healthy look.
Skin regeneration system
Day cream

Active ingredient: Bacteriorhodopsin
Excipients: hostacerin, perfume oil, cetiol, isopropyl palmitate, germaben, trilon B, carbopol, triethanolamine, citric acid

Night cream

Active ingredient: Bacteriorhodopsin
Excipients: vaseline, vaseline oil, methyl ether of p-oxybenzoic acid, propylene glycol, trilon B, cetostearyl alcohol
Relieves itching, eliminates peeling, eliminates plaque
Removes toxins and stimulates the growth
of healthy cells
Activates
the metabolic processes
Restores skin turgor
and smoothes
wrinkles
The mechanism of action of the skin regeneration system from "BIOS"
The light-sensitive protein bacteriorhodopsin ensures the delivery of retinoids to the cell nucleus
Under the influence of light quantum, bacteriorhodopsin triggers metabolic processes
in cells

Retinoid delivery

Light quantum

New cells

The process of generating new healthy cells is activated
01
02
03
Application of BIOS creams
We have ensured that the use of creams is as comfortable as possible for you. A thin layer of the cream is applied on the clean surface of the affected areas of the skin.
Application
Apply the cream strictly according to the instructions. Only in this case will youachieve the desired result. Our creams were tested in clinical conditions which produced results proving the creams’ effectiveness.

Doctors recommend using the cream for diseases such as psoriasis, atopic dermatitis, and neurodermatitis.
What experts say about our creams
The problem of psoriasis, neurodermatitis and atopic dermatitis is currently very acute. Not only adults but also children are susceptible to these diseases. Ecology, food quality, and the pace of life contribute to the spread of these diseases among people.

There is no medicine that can eradicate all of these problems forever,but there is a way to properly care for special skin to avoid spreading and aggravating the situation. The cream acts quickly and effectively.

The first results are already visible in the first week of use, confirmed by the accumulated experience. By strictly adhering to the usage instructions, you will quickly achieve the desired result.

«Results are already visible in the first week...»

Author of the patent for
the invention on the use of bacteriorhodopsin in medicine
and cosmetology, pediatrician
E.Grishkova
Chronic inflammatory skin conditions such as atopic dermatitis and psoriasis are caused by complex interactions between a variety of genetic and environmental factors. These life-ruining chronic skin diseases present with a pattern of repeated exacerbation and remission. A growing body of evidence supports the use of targeted therapies in the treatment of atopic dermatitis and psoriasis. Subcutaneously or intravenously injected antibodies targeting the cytokines IL-4, IL-13, and IL-17, which are implicated in the immunopathogenesis of chronic skin disorders, are among the systemic treatments being investigated. These antibody-based therapies clearly showed improved clinical outcomes. However, they are costly, as a single dose can cost more than $1,500 USD, and annual treatment can cost as much as $60,000 USD or more. For many people, these therapies are simply not affordable.

Fortunately, there is hope and you can have affordable cost-effective treatment for atopic dermatitis and psoriasis. That happens with the introduction of a new topical formulations based on bacteriorhodopsin, a biotechnologically produced naturally occurring protein that has activities of vitamin A. Vitamin A is implicated in various physiological processes in the body, including regulation of the immune responses. It promotes differentiation of regulatory T cells which exhibit anti-inflammatory properties and play a key role in development of remission in chronic inflammatory diseases such as atopic dermatitis and psoriasis. With the introduction of bacteriorhodopsin-based topical formulations, for the first time in dermatology history, skin experts can tell their atopic dermatitis and psoriasis patients that their condition would improve.

«Welcome to the future!»

Author of the patent for

the invention on the use of bacteriorhodopsin in medicine

and cosmetology

Professor of Immunology

Kansas City University of Medicine and Biosciences

Alex Shnyra MD, PhD

We have developed a unique technology for producing bacteriorhodopsin in large quantities. There is no such technology in the world. Our development has allowed us to create unique skin care creams for psoriasis, neurodermatitis, atopic dermatitis. There are no analogues of our creams. The use of creams makes the skin beautiful and healthy, and the quality of a person's life becomes different, not like they were once ill.

«We have developed a unique technology...»

General Director of LLC " Rodopsin. New technologies", Candidate of Chemical Sciences, biophysicist.
S. Tyurin
NAVIGATION
Main page
Photos before and after
Instruction
Patents
PRODUCTS
Day cream
Night cream
Expert reviews
Consultation
COMPANY
Bank details
Privacy Policy
Partners
Contact details
© 2021 Rhodopsin
website development: borisovstudio
NEWS